The US FDA has granted Silvergate Pharmaceuticals approval to market Epaned (enalapril maleate) powder for oral solution to treat high blood pressure for patients as young as one month – providing not only a new option for adults who may have difficulty swallowing pills, but also for babies and children with pediatric hypertension.
As an oral solution formulation, Epaned enables accurate dosing and has a taste that appeals to children, which may help...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
